MABLYTICS Trademark

Trademark Overview

On Friday, January 28, 2022, a trademark application was filed for MABLYTICS with the United States Patent and Trademark Office. The USPTO has given the MABLYTICS trademark a serial number of 97243599. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 25, 2024. This trademark is owned by MABLYTICS, INC.. The MABLYTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; Pharmaceutical preparations and substances for the treatment of immune system diseases and disorders; all of the foregoing containing monoclonal antibodies
mablytics

General Information

Serial Number97243599
Word MarkMABLYTICS
Filing DateFriday, January 28, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements

Description of MarkThe mark consists of a chevron design which is pointing at the word "MABLYTICS".
Goods and ServicesPharmaceutical preparations and substances for the treatment of oncological diseases and disorders; Pharmaceutical preparations and substances for the treatment of immune system diseases and disorders; all of the foregoing containing monoclonal antibodies
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMABLYTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameMABLYTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 25, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2023SOU EXTENSION 1 GRANTED
Monday, August 7, 2023SOU EXTENSION 1 FILED
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 16, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, November 16, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 16, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, November 16, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 9, 2022ASSIGNED TO EXAMINER
Friday, August 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 30, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 30, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 2, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 1, 2022NEW APPLICATION ENTERED

Related Keywords

mablytics diseases pharmaceutical treatment disorders substances preparations monoclonal antibodies containing system